SEMFYNLY
LIVE

Serial Number

79451072

Owner

Sandoz AG

Filing Date

Mar 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

SEMFYNLY Trademark

Serial Number: 79451072

SEMFYNLY is a trademark filed by Sandoz AG on March 20, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Sandoz AG (3 trademarks)

Viaduktstrasse 3

Entity Type: 03

Trademark Details

Filing Date

March 20, 2026

Registration Date

Not Registered

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all the aforesaid goods for human use

Filing History

LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 11, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 4, 2026 REPR